Opioid antagonists
Lundbeck and Biogaran fight in Milan and Paris over drug for alcohol dependence
Nalmefene treats alcohol dependence, a major public health concern in the EU. At the UPC a battle over two patents related to the drug is now unfolding between Danish pharma company Lundbeck and Frenc
...
7 April 2026 by Konstanze Richter